Growth Metrics

Vanda Pharmaceuticals (VNDA) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.32%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -10.19%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 24.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.92%
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn -7.95%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -7.95%
Dec 31, 2025 5.44%
Sep 30, 2025 12.95%
Jun 30, 2025 5.08%
Mar 31, 2025 5.77%
Dec 31, 2024 4.66%
Sep 30, 2024 2.35%
Jun 30, 2024 6.42%
Mar 31, 2024 -1.16%
Dec 31, 2023 -20.83%
Sep 30, 2023 -17.96%
Jun 30, 2023 -21.19%
Mar 31, 2023 -20.02%
Dec 31, 2022 -17.35%
Sep 30, 2022 -21.82%
Jun 30, 2022 -24.37%
Mar 31, 2022 -24.04%
Dec 31, 2021 -24.73%
Sep 30, 2021 -15.38%
Jun 30, 2021 -3.02%
Mar 31, 2021 -0.95%
Dec 31, 2020 7.04%
Sep 30, 2020 -5.65%
Jun 30, 2020 -11.70%
Mar 31, 2020 -9.71%
Dec 31, 2019 -12.52%
Sep 30, 2019 -9.24%
Jun 30, 2019 -11.67%
Mar 31, 2019 -15.89%
Dec 31, 2018 -16.75%
Sep 30, 2018 -15.95%
Jun 30, 2018 -15.92%
Mar 31, 2018 -6.52%
Dec 31, 2017 5.80%
Sep 30, 2017 15.16%
Jun 30, 2017 34.46%
Mar 31, 2017 25.51%
Dec 31, 2016 9.74%
Sep 30, 2016 13.75%
Jun 30, 2016 9.74%
Mar 31, 2016 41.27%
Dec 31, 2015 87.53%
Sep 30, 2015 86.25%
Jun 30, 2015 67.34%
Mar 31, 2015 39.49%
Dec 31, 2014 10.87%
Sep 30, 2014 6.03%
Jun 30, 2014 4.71%
Mar 31, 2014 -2.47%
Dec 31, 2013 -6.39%
Sep 30, 2013 -13.90%
Jun 30, 2013 -12.83%
Mar 31, 2013 -8.64%
Dec 31, 2012 143.57%
Sep 30, 2012 187.43%
Jun 30, 2012 163.03%
Dec 31, 2011 2.88%